A. Pollak et Rh. Falk, AGGRAVATION OF POSTCARDIOVERSION ATRIAL DYSFUNCTION BY SOTALOL, Journal of the American College of Cardiology, 25(3), 1995, pp. 665-671
Objectives. This study determined the effect of sotalol on atrial func
tion after electrical cardioversion of atrial fibrillation. Background
. After electrical cardioversion of atrial fibrillation, the Doppler m
itral A wave is often diminished, representing impaired atrial contrac
tile function. Sotalol is an effective atrial antiarrhythmic drug with
class III and beta-adrenergic blacking properties. Although the negat
ive inotropic effect of sotalol on the ventricle is minimal in patient
s with normal ventricular function, it may manifest negative inotropy
when ventricular function is impaired. We postulated that after cardio
version, when intrinsic atrial function is impaired, sotalol may have
an adverse effect on the atrium. Methods. Thirty seven patients enroll
ed in a randomized, double-blind study of sotalol for maintenance of s
inus rhythm were studied by quantitative Doppler echocardiography with
in 24 h of electrical cardioversion and, for those still in sinus rhyt
hm, again at 1 month. Doppler variables (E and A wave velocities and i
ntegrals) in patients receiving sotalol were compared with those in pa
tients receiving placebo. Results. After electrical cardioversion, pea
k A wave velocity and A wave time-velocity integral in the 20 patients
receiving placebo were reduced compared with normal values. In the 17
patients receiving sotalol (median dose 320 mg twice daily) these var
iables were further reduced (mean [+/-SD] peak A wave velocity 19.4 +/
- 5.5 vs. 38.4 +/- 14.7 cm/s, p < 0.001 and mean A wave Time-velocity
integral 1.7 +/- 0.6 vs. 3.4 +/- 1.4 cm, p < 0.001, in sotalol- vs. pl
acebo-treated patients, respectively). Early diastolic filling (E wave
variables) did not differ between sotalol- and placebo-treated groups
, At 1 month, five sotalol- and six placebo-treated patients remained
in sinus rhythm, and A wave variables had increased for the whole grou
p, with a greater increase in sotalol-treated patients. Conclusions. A
fter electrical cardioversion, when atrial stunning is prominent, sota
lol has a negative atrial inotropic effect, This effect may be tempora
ry, as suggested by resolution at 1 month. Negative inotropic effects
of antiarrhythmic drugs on the atrium should be considered in assessin
g Doppler variables of left ventricular filling.